GET DAILY SIGNALSCLOV vs WTW: Weighing High-Growth Medicare Momentum Against Steady Advisory Stability
Key Takeaways
- CLOV is a fast-growing Medicare Advantage and physician-enablement technology company, while WTW is a diversified global advisory, broking, and solutions firm with steadier, more mature economics.
- Recent momentum clearly favors CLOV: it is riding rapid membership growth, a top-quality plan rating, and a shift toward GAAP profitability, whereas WTW has lagged the broader market in 2026.
- Risk profiles differ sharply: CLOV carries a high beta and considerable volatility, while WTW offers lower volatility, a dividend, and stronger free cash flow.
- Relative positioning suggests CLOV is a momentum-and-growth story and WTW is a margin-expansion and efficiency story driven by its "Propel" AI initiative.
- Tickeron AI Verdict: CLOV — based on trend consistency, catalysts, and relative positioning, Tickeron's AI currently favors CLOV over WTW.
- For deeper context, explore CLOV Major News, CLOV Today's Price Move, WTW Major News, and WTW Today's Price Move.
- To see which strategies AI-driven systems are deploying across the market right now, explore Trending AI Robots.
Introduction: Two Distinct Business Models
Comparing CLOV and WTW puts two very different businesses side by side. Clover Health Investments, Corp. is a physician-enablement technology company focused on Medicare Advantage plans, a segment that has delivered explosive top-line growth but historically thin or negative profitability. Willis Towers Watson is a global advisory, broking, and solutions powerhouse that generates consistent earnings and free cash flow across more than 140 countries. This stock comparison is most relevant to investors deciding between a high-growth, higher-volatility healthcare name and a diversified, capital-returning franchise — and to traders weighing momentum and catalysts against stability and income. I also checked sector peers using Tickeron’s AI Screener to put the relative profiles in context.
CLOV Overview and Recent Performance
Clover Health Investments, Corp. operates Medicare Advantage plans and licenses its Clover Assistant software, a clinical decision-support platform for physicians. The company has reported accelerating momentum in recent quarters: first-quarter 2026 revenue rose roughly 62% year over year to about $749 million, while Medicare Advantage membership climbed more than 50% to approximately 155,000 members. Adjusted EBITDA reached about $40 million, and the company generated positive operating cash flow.
Recent market activity has been supported by several catalysts. The Centers for Medicare & Medicaid Services awarded Clover's PPO plans a five-star rating for 2027, a quality milestone that can strengthen benefit competitiveness and future enrollment. Analysts have responded favorably, with several firms initiating or maintaining Buy ratings in recent weeks. The stock has been notably volatile — its beta is well above the market average — but has outperformed its industry year to date, reflecting investor enthusiasm for the company's path toward full-year GAAP net income profitability in 2026.
WTW Overview and Recent Performance
Willis Towers Watson operates two primary segments: Risk & Broking, which provides insurance brokerage and advisory services, and Health, Wealth & Career, which delivers benefits, retirement, and compensation consulting. In its most recent quarter, WTW reported revenue of roughly $2.46 billion, up 8% year over year, with organic growth of about 4% and adjusted diluted EPS up 18%.
WTW's narrative in recent weeks has centered on "Propel," an AI acceleration plan approved in mid-2026. The company is investing approximately $625 million through 2028, targeting roughly $350 million in net run-rate savings and a 30% adjusted operating margin. Management has also completed the integration of the Newfront acquisition, which closed in early 2026. Despite solid operational execution, the stock has modestly underperformed the broader market in 2026, and consensus estimate revisions have been mixed. WTW continues to return capital through dividends and share repurchases, reinforcing its profile as a stable, cash-generative franchise.
Head-to-Head Comparison
The two companies diverge across nearly every fundamental dimension. CLOV is a concentrated, technology-enabled healthcare operator whose growth depends on Medicare Advantage enrollment, quality ratings, and medical-cost management. Its revenue base is scaling rapidly, but profitability is still emerging and its earnings stream remains less predictable. WTW is a diversified, fee-based advisory business with high retention, steady margins, and substantial free cash flow, but its growth is slower and more cyclical through corporate spending and insurance pricing.
From a risk standpoint, CLOV's elevated beta reflects higher sensitivity to market swings and to policy changes affecting Medicare. WTW's risk is more operational, tied to acquisition integration, restructuring costs, and the execution of its AI-driven margin plan. Sentiment also contrasts: CLOV has attracted positive analyst initiations and a quality-rating catalyst, while WTW has faced mixed estimate revisions and lagged the market in 2026. In terms of market positioning, CLOV offers a higher-upside, higher-volatility growth profile, whereas WTW offers lower-volatility income and efficiency-driven margin expansion.
Tickeron AI Verdict
Based on observable factors such as trend consistency, momentum, catalyst density, and relative positioning, Tickeron's AI currently favors CLOV over WTW. CLOV's combination of rapid membership growth, a five-star quality rating, improving cash generation, and a shift toward GAAP profitability presents a clearer near-term catalyst path. By contrast, WTW's efficiency program and margin targets are weighted toward 2027 and 2028, and its shares have shown weaker relative momentum. The assessment is probabilistic rather than definitive: CLOV's higher volatility and still-emerging profitability carry meaningful risk, and WTW's stability and cash flow remain attractive to a different investor profile. The AI verdict reflects current trend and catalyst alignment rather than a guarantee of future performance. I also reviewed trend data with Tickeron’s AI Trend Prediction Engine to confirm the directional signals.
Exploring AI-Driven Strategies
One resource I return to regularly is Tickeron’s Trending AI Robots. It highlights automated systems currently performing well across different timeframes and risk levels, giving a practical way to compare verified historical statistics without building custom models from scratch.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
WTW in upward trend: price rose above 50-day moving average on October 20, 2026
WTW moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 23 of 34 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 68%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on WTW as a result. In 63 of 106 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.
The Moving Average Convergence Divergence (MACD) for WTW just turned positive on October 08, 2026. Looking at past instances where WTW's MACD turned positive, the stock continued to rise in 32 of 48 cases over the following month. The odds of a continued upward trend are 67%.
The 10-day moving average for WTW crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Following a +6.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where WTW advanced for three days, in 143 of 308 cases, the price rose further within the following month. The odds of a continued upward trend are 46%.
Bearish Trend Analysis
The 10-day RSI Indicator for WTW moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 18 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 53%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 29 of 70 cases where WTW's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 41%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WTW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.
WTW broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for WTW entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. WTW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 47 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 50 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock slightly better than average.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.874) is normal, around the industry mean (2.599). P/E Ratio (19.786) is within average values for comparable stocks, (18.024). Projected Growth (PEG Ratio) (1.265) is also within normal values, averaging (8.322). Dividend Yield (0.012) settles around the average of (0.045) among similar stocks. P/S Ratio (2.990) is also within normal values, averaging (2.968).
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of weight management services
Industry InsuranceBrokersServices
Advertisement